Is anti-cholinesterase therapy of Alzheimer's disease delaying progression? [PDF]
During the last decade, a systematic effort to develop a pharmacological treatment for Alzheimer's disease (AD) resulted in three drugs being registered for the first time in the US and Europe.
Giacobini, E.
core
Switching from Donepezil or Rivastigmine to Galantamine in Clinical Practice [PDF]
Keith R. Edwards +2 more
openalex +1 more source
Comparison of two pharmaceutical production processes using different eco-efficiency measuring methods [PDF]
Aelterman, Wim +7 more
core +1 more source
Richard A Hansen1, Gerald Gartlehner2, Aaron P Webb1, Laura C Morgan3, Charity G Moore4, Daniel E Jonas31School of Pharmacy, 3Cecil G Sheps Center for Health Services Research, University of North Carolina, Chapel Hill, NC, USA; 2Department for Evidence ...
Richard A Hansen +5 more
doaj
GALANTAMINE IMPROVES GAIT PERFORMANCE IN PATIENTS WITH ALZHEIMER'S DISEASE [PDF]
Frédéric Assal +4 more
openalex +1 more source
Attenuated Mismatch Negativity in Attenuated Psychosis Syndrome Predicts Psychosis: Can Galantamine-Memantine Combination Prevent Psychosis? [PDF]
Maju Mathew Koola
openalex +1 more source
Adjunctive galantamine, but not donepezil, enhances the antipsychotic-like effect of raclopride in rats [PDF]
Charlotte Wiker +4 more
openalex +1 more source
Donepezil is more effective than galantamine for mild to moderate Alzheimer’s disease [PDF]
John O. Warner
openalex +1 more source
Ameliorative effect of galantamine on acetic acid-induced colitis in rats
Mohsen Minaiyan +2 more
openalex +1 more source

